Cancer Biomarkers Funding Opportunities

Title Announcement # Expiration Datesort descending Activity Code Contact
AHEAD (Advancing Head and Neck Cancer Early Detection Research) RFA-DE-23-013 (U01 Clinical Trial Not Allowed) 03/15/2023 U01 Wendy Wang, Ph.D., M.Sc.
Notice of Special Interest (NOSI): Single-Cell Proteomics for Interrogating Premalignant and Early Malignant Lesions NOT-CA-20-044 05/08/2023 Richard Mazurchuk, Ph.D
Assay Validation of High Quality Markers for Clinical Studies in Cancer PAR-20-313 (UH2/UH3 Clinical Trial Not Allowed) 10/11/2023 UH2, UH3 Lynn Sorbara, Ph.D.
Assay Validation of High Quality Markers for Clinical Studies in Cancer PAR-20-314 (UH3 Clinical Trials Not Allowed) 10/11/2023 UH3 Lynn Sorbara, Ph.D.
Notice of Special Interest (NOSI): Leveraging Real-World Imaging Data for Artificial Intelligence-based Modeling and Early Detection of Abdominal Cancers NOT-CA-21-028 01/08/2024 Natalie Abrams, Ph.D.
Pancreatic Cancer Detection Consortium: Research Units PAR-21-334 (U01 Clinical Trial Optional) 06/12/2024 U01 Sharmistha Ghosh-Janjigian, Ph.D.
Notice of Special Interest: Administrative Supplements for Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed) NOT-OD-22-202 04/16/2025 Nancy J. Emenaker, Ph.D., R.D.N., L.D., F.A.N.D.
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research PAR-22-099 (R01 Clinical Trial Optional) 05/08/2025 R01 Richard Mazurchuk, Ph.D.
Notice of Special Interest (NOSI): Utilization of Cohorts and Prospective Study Designs for Liquid Biopsy Assay Validation for Early Detection of Cancers NOT-CA-23-004 07/02/2025 Matthew Young, Ph.D.
Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes PAR-22-131 (R01 Clinical Trial Optional) 09/08/2025 R01 Richard Mazurchuk, Ph.D.